The historical rank and industry rank for Pilulka Lekarny AS's Days Payable or its related term are showing as below:
XPRA:PINK'
s Days Payable Range Over the Past 10 Years
Min: 56.66 Med: 62.63 Max: 67.74
Current: 67.74
During the past 6 years, Pilulka Lekarny AS's highest Days Payable was 67.74. The lowest was 56.66. And the median was 62.63.
XPRA:PINK's Days Payable is ranked better than 56.67% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs XPRA:PINK: 67.74
Pilulka Lekarny AS's Days Payable
stayed the same
from Jun. 2024 (0.00) to Dec. 2025 (0.00).
Pilulka Lekarny AS Days Payable Related Terms
Pilulka Lekarny AS Days Payable Historical Data
* Premium members only.
The historical data trend for Pilulka Lekarny AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pilulka Lekarny AS Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Days Payable distribution charts can be found below:
* The bar in red indicates where Pilulka Lekarny AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pilulka Lekarny AS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS (XPRA:PINK) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pilulka Lekarny AS and its competitors. Over the past decade, Pilulka Lekarny AS's Days Payable has ranged from 56.66 to 67.74. According to the industry distribution chart, Pilulka Lekarny AS ranks #263 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 43.3%.
Is Pilulka Lekarny AS's Days Payable too high?
Pilulka Lekarny AS's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 56.66 to a high of 67.74. Based on the distribution chart, Pilulka Lekarny AS ranks #263 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pilulka Lekarny AS has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pilulka Lekarny AS ranks #263 out of 607 companies for Days Payable. This puts Pilulka Lekarny AS in the upper half of its industry. The industry median Days Payable is 57.13. Historically, Pilulka Lekarny AS's own Days Payable has ranged from 56.66 to 67.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pilulka Lekarny AS and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pilulka Lekarny AS's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč113.58, compared to a current price of Kč108.50 — trading 4.5% below its estimated fair value. The current Days Payable is 0.00. Pilulka Lekarny AS's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?
Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued.
The current stock price of Kč108.50 is trading 4.5% below its estimated GF Value™ of Kč113.58.
GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.
Key valuation signals for XPRA:PINK:
Days Payable: 0.00
GF Value™: Kč113.58 vs. price of Kč108.50 (4.5% below fair value)
No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
48GF Score
Get the complete analysis for XPRA:PINK
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPRA:PINK has been successfully added to your 